|
|
 |
|
Viewing report
|
|
|
|
Cephalon, Inc.: SWOT Analysis & Company Profile
Business Review, Nov 2010, Pages: 27
Synopsis
Business Review’s Cephalon, Inc. contains a company overview, key facts, locations and subsidiaries, news and events as well as a SWOT analysis of the company.
Summary
This SWOT Analysis company profile is a crucial resource for industry executives and anyone looking to quickly understand the key information concerning Cephalon, Inc.’s business.
Business Review’s “Cephalon, Inc. SWOT Analysis & Company Profile” reports utilize a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format.
Business Review strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report.
Scope
- Examines and identifies key information and issues about (Cephalon, Inc.) for business intelligence requirements
- Studies and presents Cephalon, Inc.’s strengths, weaknesses, opportunities (growth potential) and threats (competition). Strategic and operational business information is objectively reported.
- The profile contains business operations, the company history, major products and services, prospects, key competitors, structure and key employees, locations and subsidiaries.
Reasons To Buy
- Quickly enhance your understanding of the company.
- Obtain details and analysis of the market and competitors as well as internal and external factors which could impact the industry.
- Increase business/sales activities by understanding your competitors’ businesses better.
- Recognize potential partnerships and suppliers.
- Obtain yearly profitability figures
Key Highlights
Cephalon, Inc. (Cephalon) is an international biopharmaceutical company, engaged in the research, development and marketing of innovative therapeutic products. The company develops products for the treatment of cancer, pain, central nervous system, and inflammatory disease. The product portfolio of Cephalon includes modafinil tablets, fentanyl buccal tablets, arsenic trioxide injections, oral transmucosal fentanyl citrate and cyclobenzaprine hydrochloride extended release capsules. Cephalon ranks among the world’s fastest-growing biopharmaceutical companies and the Fortune 1000. The company offers more than 150 branded and generic products in 100 countries across the world. Cephalon operates through its wholly owned subsidiaries worldwide. The company is headquartered in Frazer, Pennsylvania, the US.
|
|
|
|
